Recursion (RXRX), a clinical stage TechBio company, has announced its participation in three major upcoming investor conferences in June 2025. The company will present at the Jefferies Global Healthcare Conference on June 5, the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, and the TDCowen 4th Annual Tools/Dx Revolution Conference on June 23. Interested parties can access the webcasts of these presentations through the events section of Recursion's Investor Relations website at ir.recursion.com.
Recursion (RXRX), un'azienda TechBio in fase clinica, ha annunciato la sua partecipazione a tre importanti conferenze per investitori previste per giugno 2025. La societ脿 presenter脿 alla Jefferies Global Healthcare Conference il 5 giugno, alla Goldman Sachs 46th Annual Global Healthcare Conference il 10 giugno e alla TDCowen 4th Annual Tools/Dx Revolution Conference il 23 giugno. Gli interessati possono seguire le webcasting di queste presentazioni nella sezione eventi del sito Investor Relations di Recursion all'indirizzo ir.recursion.com.
Recursion (RXRX), una empresa TechBio en etapa cl铆nica, ha anunciado su participaci贸n en tres importantes conferencias para inversores que se llevar谩n a cabo en junio de 2025. La compa帽铆a presentar谩 en la Jefferies Global Healthcare Conference el 5 de junio, en la Goldman Sachs 46th Annual Global Healthcare Conference el 10 de junio y en la TDCowen 4th Annual Tools/Dx Revolution Conference el 23 de junio. Los interesados pueden acceder a las transmisiones en vivo de estas presentaciones a trav茅s de la secci贸n de eventos del sitio web de Relaciones con Inversores de Recursion en ir.recursion.com.
Recursion (RXRX), une entreprise TechBio en phase clinique, a annonc茅 sa participation 脿 trois grandes conf茅rences pour investisseurs pr茅vues en juin 2025. La soci茅t茅 pr茅sentera lors de la Jefferies Global Healthcare Conference le 5 juin, de la Goldman Sachs 46th Annual Global Healthcare Conference le 10 juin, et de la TDCowen 4th Annual Tools/Dx Revolution Conference le 23 juin. Les personnes int茅ress茅es peuvent acc茅der aux webcasts de ces pr茅sentations via la section 茅v茅nements du site Relations Investisseurs de Recursion 脿 l'adresse ir.recursion.com.
Recursion (RXRX), ein TechBio-Unternehmen in der klinischen Phase, hat seine Teilnahme an drei bedeutenden Investorenkonferenzen im Juni 2025 angek眉ndigt. Das Unternehmen wird auf der Jefferies Global Healthcare Conference am 5. Juni, der Goldman Sachs 46th Annual Global Healthcare Conference am 10. Juni und der TDCowen 4th Annual Tools/Dx Revolution Conference am 23. Juni pr盲sentieren. Interessierte k枚nnen die Webcasts dieser Pr盲sentationen 眉ber den Veranstaltungsbereich der Investor-Relations-Website von Recursion unter ir.recursion.com abrufen.
Positive
None.
Negative
None.
Salt Lake City, May 30, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:
Jefferies Global Healthcare Conference 鈥� Thursday, June 5, 2025
Goldman Sachs 46th Annual Global Healthcare Conference 鈥� Tuesday, June 10, 2025
Webcasts may be found in the events section of the Recursion Investor Relations website at . About Recursion Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world鈥檚 largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale 鈥� up to millions of wet lab experiments weekly 鈥� and massive computational scale 鈥� owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Toronto, Montr茅al, New York, London, Oxford area, and the San Francisco Bay area. Learn more at , or connect on and .
When is Recursion (RXRX) presenting at the Jefferies Global Healthcare Conference 2025?
Recursion will present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025.
Which investor conferences will Recursion (RXRX) attend in June 2025?
Recursion will attend three conferences: Jefferies Global Healthcare Conference (June 5), Goldman Sachs Global Healthcare Conference (June 10), and TDCowen Tools/Dx Revolution Conference (June 23).
How can investors access Recursion's (RXRX) conference presentations?
Investors can access the webcasts through the events section of Recursion's Investor Relations website at ir.recursion.com.
What is Recursion's (RXRX) business focus?
Recursion is a clinical stage TechBio company focused on decoding biology to radically improve lives.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, to receive support.
